Literature DB >> 26715820

Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.

Kenichiro Nakagawa1, Tomoyuki Koike1, Katsunori Iijima1, Masahiro Saito1, Hiroki Kikuchi1, Waku Hatta1, Nobuyuki Ara1, Kaname Uno1, Naoki Asano1, Tooru Shimosegawa1.   

Abstract

AIM: To clarify the pathogenesis of gastroesophageal reflux disease symptoms in non-erosive reflux disease (NERD) patients.
METHODS: Thirty-five NERD patients with persistent symptoms, despite taking rabeprazole 10 mg twice daily for at least 8 wk, were included in this study. All patients underwent 24 h combined impedance - pH on rabeprazole. The symptom index (SI) was considered to be positive if ≥ 50%, and proximal reflux episodes were determined when reflux reached 15 cm above the proximal margin of the lower esophageal sphincter.
RESULTS: In 14 (40%) SI-positive patients, with liquid weakly acid reflux, the occurrence rate of reflux symptoms was significantly more frequent in proximal reflux episodes (46.7%) than in distal ones (5.7%) (P < 0.001). With liquid acid reflux, there were no significant differences in the occurrence rate of reflux symptoms between proximal reflux episodes (38.5%) and distal ones (20.5%) (NS). With mixed liquid-gas weakly acid reflux, the occurrence rate of reflux symptoms in proximal reflux episodes was significantly more frequent (31.0%) than in distal reflux ones (3.3%) (P < 0.001). With mixed liquid-gas acid reflux, there were no significant differences in the occurrence rate of reflux symptoms between proximal reflux episodes (29.4%) and distal ones (14.3%) (NS).
CONCLUSION: The proximal extent of weakly acidic liquid and mixed liquid-gas reflux is a major factor associated with reflux perception in SI-positive patients on proton pump inhibitor therapy.

Entities:  

Keywords:  Impedance-pH monitoring; Non-erosive reflux disease; Proton pump inhibitor; Proximal reflux; Symptomatic reflux episodes

Mesh:

Substances:

Year:  2015        PMID: 26715820      PMCID: PMC4679769          DOI: 10.3748/wjg.v21.i47.13352

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Authors:  M F Vela; L Camacho-Lobato; R Srinivasan; R Tutuian; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

3.  Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Authors:  Edoardo Savarino; Patrizia Zentilin; Radu Tutuian; Daniel Pohl; Lorenzo Gemignani; Alberto Malesci; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

4.  The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.

Authors:  G J Wiener; J E Richter; J B Copper; W C Wu; D O Castell
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

5.  Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings.

Authors:  D Sifrim; R Holloway; J Silny; Z Xin; J Tack; A Lerut; J Janssens
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.

Authors:  Yukie Kohata; Yasuhiro Fujiwara; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

7.  The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis.

Authors:  S Tew; G G Jamieson; I Pilowsky; J Myers
Journal:  Dis Esophagus       Date:  1997-01       Impact factor: 3.429

8.  Proximal oesophagus: the added value in understanding GORD symptoms.

Authors:  M Cicala; F I Habib; S Emerenziani
Journal:  Neurogastroenterol Motil       Date:  2009-08       Impact factor: 3.598

9.  Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.

Authors:  T Lind; T Havelund; R Carlsson; O Anker-Hansen; H Glise; H Hernqvist; O Junghard; K Lauritsen; L Lundell; S A Pedersen; A Stubberöd
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

10.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more
  2 in total

Review 1.  Refractory Heartburn: A Challenging Problem in Clinical Practice.

Authors:  Gerson Domingues; Joaquim Prado P Moraes-Filho; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

2.  Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.

Authors:  Nunzio Ranaldo; Giuseppe Losurdo; Andrea Iannone; Mariabeatrice Principi; Michele Barone; Massimo De Carne; Enzo Ierardi; Alfredo Di Leo
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.